Altesa BioSciences, Inc.

Altesa BioSciences, Inc. is a clinical-stage pharmaceutical company focused on pioneering novel approaches to prevent and treat viral respiratory infections, a leading cause of COPD and asthma exacerbations. Altesa BioSciences, Inc. is dedicated to disrupting the current COPD treatment model by targeting the root cause of acute respiratory exacerbations. The company's primary focus is on rhinovirus, the most prevalent respiratory virus worldwide. Located in Atlanta, GA, Altesa BioSciences, Inc. strives to improve patient outcomes and quality of life through innovative therapeutic solutions.

Altesa BioSciences, Inc. is committed to developing and delivering cutting-edge treatments that address the unmet needs in respiratory disease management. The company's research and development efforts are geared towards preventing the long-term consequences of chronic inflammation, hospitalizations, and mortality associated with COPD and asthma. Altesa BioSciences, Inc. aims to set a new standard in respiratory care through its dedication to innovation and patient-centric solutions.

With its headquarters in Atlanta, GA, Altesa BioSciences, Inc. is positioned to drive significant advancements in the biotechnology sector. The company is actively working to enhance its portfolio and expand its reach in the pharmaceutical market. We invite the management team at Altesa BioSciences, Inc. to create a customized and exclusive company showcase and product listing on our platform to further amplify their presence and connect with a broader audience.